Cargando…
Clinical Data Interchange Standards in Clinical Trials on Alzheimer’s Disease
OBJECTIVE: The Clinical Data Interchange Standards Consortium (CDISC) proposed outcome measures for clinical trials on Alzheimer’s disease (AD) in the Therapeutic Area User Guide for AD (TAUG-AD). To investigate how well the clinical trials on AD registered in the ClinicalTrials.gov complied with th...
Autores principales: | Na, Riyoung, Bae, Jong Bin, Jung, Sue Hyun, Kim, Ki Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633174/ https://www.ncbi.nlm.nih.gov/pubmed/36327961 http://dx.doi.org/10.30773/pi.2022.0149 |
Ejemplares similares
-
Clinical data interchange standards consortium: A bridge to overcome data standardisation
por: Babre, Deven Kishor
Publicado: (2013) -
Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey
por: Facile, Rhonda, et al.
Publicado: (2022) -
A use-case analysis of Clinical Data Interchange Standards Consortium/Study Data Tabulation Model in academia in an investigator-initiated clinical trial
por: Takahara, Shizuko, et al.
Publicado: (2022) -
A Systematic Review of Nonpharmacological Interventions for Moderate to Severe Dementia: A Study Protocol for a Systematic Review and Meta-Analysis
por: Na, Riyoung, et al.
Publicado: (2018) -
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022)